Evoke Pharma (NASDAQ:EVOK) reported its Q3 earnings results on Thursday, November 9, 2023 at 08:30 AM.
Here’s what investors need to know about the announcement.
Earnings
Evoke Pharma beat estimated earnings by 17.74%, reporting an EPS of $-0.51 versus an estimate of $-0.62.
Revenue was up $730 thousand from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.17 which was followed by a 3.55% drop in the share price the next day.
Here’s a look at Evoke Pharma’s past performance:
| Quarter | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|
| EPS Estimate | -0.73 | -0.58 | -0.53 | -0.66 |
| EPS Actual | -0.56 | -0.67 | -0.54 | -0.60 |
| Revenue Estimate | 1.10M | 1.00M | 890K | 570K |
| Revenue Actual | 1.13M | 810K | 796K | 832K |
To track all earnings releases for Evoke Pharma visit their earnings calendar here.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
